Kong Garheng
- SEC CIK
- 0001435183
No open-market purchases or sales filed in the past year.
Current role at each company
- XERS Xeris Biopharma Holdings, Inc.Directoras of Jun 5, 2026
- LH Labcorp Holdings Inc.Directoras of Feb 13, 2026
- VERO Venus Concept Inc.Directoras of Mar 28, 2023
- ALIM Alimera Sciences IncDirectoras of Jan 6, 2023
- SBBP Strongbridge Biopharma plcDirectoras of Oct 6, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Kong Garheng as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VERO Venus Concept Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2022 (view filing) | Nov 18 | 4 days | Kong GarhengDirector, 10% Owner | PPurchase | +3.35M | $0.20 | +$670.0K | –335.0K after | Derivative |
| Dec 17, 2021 (view filing) | Dec 15 | 2 days | Kong GarhengDirector, 10% Owner | PPurchase | +1.60M | $1.25 | +$2.00M | +30.8%6.80M after |